or
forgot password

    • cancer clinical trials in asheville, NC

    • This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.
    Research Site
    Asheville, North Carolina
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Renal Cell, Kidney Neoplasms
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Lung Cancer
    Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Veterans Affairs Medical Center - Asheville
    Asheville, North Carolina 28805
    Lung Cancer
    CPG 7909 Injection in Non-Small Cell Lung Cancer
    Cancer Care of Western North Carolina
    Asheville, North Carolina 28801
    Carcinoma, Non-Small Cell Lung
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Veterans Affairs Medical Center - Asheville
    Asheville, North Carolina 28805
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Gastrointestinal Stromal Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Pancreatic Cancer
    Iressa Versus Docetaxel (Taxotere)
    Research Site
    Asheville, North Carolina
    Non-Small-Cell Lung Carcinoma
    A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Renal Cell
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Asheville Hematology & Oncology Associates, PA
    Asheville, North Carolina 28801
    Non-Small Cell Lung Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    Hope A Women's Cancer Center
    Asheville, North Carolina 28801
    Cervical Cancer
    Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
    Veterans Affairs Medical Center - Asheville
    Asheville, North Carolina 28805
    Lung Cancer
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Asheville, North Carolina
    Colorectal Cancer, Metastases
    SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Renal Cell
    FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
    Research Site
    Asheville, North Carolina
    Chronic Lymphocytic Leukemia
    Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
    Hope: A Woman's Cancer Center
    Asheville, North Carolina 28816
    Ovarian Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cancer Care of WNC
    Asheville, North Carolina 28801
    Lung Cancer, Non-small-cell Lung Carcinoma
    Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Non-Small-Cell Lung
    A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Gastrointestinal Neoplasm
    Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Lung Neoplasms, Carcinoma, Non-small Cell Lung
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Esophageal Cancer
    Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Tumors Metastatic to Brain
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Colorectal Neoplasms
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Hope A Women's Cancer Center

    Trial Locations
    Hope A Women's Cancer Center
    Asheville Radiology
    Ovarian Neoplasms
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Hope A Women's Cancer Center
    Asheville, North Carolina 28801
    Sarcoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Lymphoma
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Renal Cell
    Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Prostatic Neoplasms
    Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Colorectal Neoplasms
    Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Neoplasms
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1852
    Asheville, North Carolina 28801
    Crohn's Disease
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Osteoporosis
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Asheville, North Carolina
    Diabetes Mellitus, Type 2
    AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Pancreatic Neoplasms
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Asheville, North Carolina
    Type 2 Diabetes Mellitus
    Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Breast Neoplasms
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Asheville, North Carolina
    Refractory Melanoma
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Non-Small-Cell Lung
    A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Non-Small-Cell Lung
    Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Non-Small-Cell Lung, Lung Neoplasms
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Recurrent Melanoma, Stage IV Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Brain and Central Nervous System Tumors
    Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Carcinoma, Non-Small-Cell Lung
    A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Breast Neoplasms
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Asheville Cardiology Associates
    Asheville, North Carolina 28803
    Atrial Fibrillation, Atrial Flutter
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Advanced HIV Infection
    Registration and Informed Consent Study for the Childhood Cancer Research Network
    Mission Hospitals - Memorial Campus
    Asheville, North Carolina 28801
    Unspecified Childhood Solid Tumor, Protocol Specific
    A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Breast Neoplasms
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Asheville, North Carolina 28801
    Neoplasms
    Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
    Mission Hospitals Inc
    Asheville, North Carolina 28801
    Adrenocortical Carcinoma, Localized Resectable Neuroblastoma, Precancerous Condition